Journal article · 2026 · Open access
Immune checkpoint inhibitor–induced myocarditis is dependent on CD8 T cell–derived TNF and TNFR2 signaling
The Journal of Experimental Medicine, 223(4) · Published 14 January 2026 · DOI 10.1084/jem.20251717
In brief
“Immune checkpoint inhibitor–induced myocarditis is dependent on CD8 T cell–derived TNF and TNFR2 signaling” is a 2026 journal article by Kathrynne A. Warrick and 9 co-authors, published in The Journal of Experimental Medicine. OpenAlex counts 10 citations as of 17 November 2026, which puts it in the top 2% of works published in 2026 by citations. It is open access: the full text is free to read at PubMed Central.
- Citations
- 10
- Most cited in
- 2026 (10)
- Field-weighted impact
- 24.02
- References
- 65
- Authors
- 10
Abstract
Immune checkpoint inhibitors (ICIs) improve cancer survival but can trigger immune-related adverse events. Among these, fulminant myocarditis is an often fatal complication with limited therapies. We developed a mouse model employing cardiomyocyte-restricted antigen expression to define how ICIs drive cardiac autoimmunity. Combined cytotoxic T cell antigen-4 (αCTLA-4) and programmed death-1 (αPD-1) blockade uniquely induced robust expansion of antigen-specific CD8 T cells, myocardial inflammation, and lethal arrhythmias. PD-1 blockade alone permitted the priming and effector differentiation of naive autoreactive CD8 T cells, whereas concomitant CTLA-4 inhibition amplified cardiac pathology. Unexpectedly, myocardial injury was independent of perforin-mediated cytotoxicity but critically depended on T cell-derived TNF, which promoted myeloid recruitment, cytokine production, and arrhythmogenesis. Genetic ablation of CD8 T cell-derived tumor necrosis factor (TNF) or TNF receptor 2 (TNFR2) blockade prevented cardiotoxicity while preserving antitumor efficacy. These findings establish a TNF-TNFR2-driven inflammatory circuit downstream of autoreactive CD8 T cells as a central mechanism of ICI myocarditis and a strategy to uncouple cardiotoxicity from immunotherapy benefits.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Warrick, K. A., Johansen, A. K. Z., Jiao, M., Linnemann, M. E., Saha, I., Lin, S. J., Vallez, C. N., Hagan, T., Molkentin, J. D., & Pasare, C. (2026). Immune checkpoint inhibitor–induced myocarditis is dependent on CD8 T cell–derived TNF and TNFR2 signaling. The Journal of Experimental Medicine, 223(4). https://doi.org/10.1084/jem.20251717
MLA 9
Warrick, Kathrynne A., et al. “Immune checkpoint inhibitor–induced myocarditis is dependent on CD8 T cell–derived TNF and TNFR2 signaling.” The Journal of Experimental Medicine, vol. 223, no. 4, 2026. https://doi.org/10.1084/jem.20251717.
Chicago
Warrick, Kathrynne A., Anne Katrine Z. Johansen, Mengchi Jiao, Megan E. Linnemann, Irene Saha, Suh‐Chin J. Lin, Charles N. Vallez, Thomas Hagan, Jeffery D. Molkentin, and Chandrashekhar Pasare. 2026. “Immune checkpoint inhibitor–induced myocarditis is dependent on CD8 T cell–derived TNF and TNFR2 signaling.” The Journal of Experimental Medicine 223 (4). https://doi.org/10.1084/jem.20251717.
Harvard
Warrick, K. A. et al. (2026) ‘Immune checkpoint inhibitor–induced myocarditis is dependent on CD8 T cell–derived TNF and TNFR2 signaling’, The Journal of Experimental Medicine, 223(4). doi:10.1084/jem.20251717.
IEEE
K. A. Warrick et al., “Immune checkpoint inhibitor–induced myocarditis is dependent on CD8 T cell–derived TNF and TNFR2 signaling,” The Journal of Experimental Medicine, vol. 223, no. 4, 2026, doi: 10.1084/jem.20251717.
BibTeX
@article{warrick2026immune,
title = {{Immune checkpoint inhibitor–induced myocarditis is dependent on CD8 T cell–derived TNF and TNFR2 signaling}},
author = {Warrick, Kathrynne A. and Johansen, Anne Katrine Z. and Jiao, Mengchi and Linnemann, Megan E. and Saha, Irene and Lin, Suh‐Chin J. and Vallez, Charles N. and Hagan, Thomas and Molkentin, Jeffery D. and Pasare, Chandrashekhar},
journal = {The Journal of Experimental Medicine},
year = {2026},
volume = {223},
number = {4},
doi = {10.1084/jem.20251717},
url = {https://doi.org/10.1084/jem.20251717}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- immune checkpoint inhibitor-induced myocarditis
- CD8+ T cells
- TNF signaling
- TNF receptor 2
- CTLA-4 blockade
- anti-PD-1 therapy
- cardiac autoimmunity
- arrhythmogenesis
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Warrick, K. A., Johansen, A. K. Z., Jiao, M., Linnemann, M. E., Saha, I., Lin, S. J., Vallez, C. N., Hagan, T., Molkentin, J. D., & Pasare, C. (2026). Immune checkpoint inhibitor–induced myocarditis is dependent on CD8 T cell–derived TNF and TNFR2 signaling. The Journal of Experimental Medicine, 223(4). https://doi.org/10.1084/jem.20251717
How many times has this paper been cited?
10 times, according to OpenAlex on 17 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at PubMed Central: sign in and open the PDF from this page.
Who wrote this paper?
Kathrynne A. Warrick, Anne Katrine Z. Johansen, Mengchi Jiao, Megan E. Linnemann, Irene Saha, Suh‐Chin J. Lin, Charles N. Vallez, Thomas Hagan, Jeffery D. Molkentin, Chandrashekhar Pasare.
What is the DOI of this paper?
10.1084/jem.20251717, permanently at https://doi.org/10.1084/jem.20251717. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 17 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.